Masriana Hassan1*, Nur Fatin Zalikha Zailan1, Chee Hui Yee2, Eusni Rahayu Mohd Tohit1, Maha Abdullah1, Syafinaz Amin Nordin2 and Irmi Zarina Ismail3
1. Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
2. Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
3. Department of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
*Corresponding author: Masriana Hassa.
ABSTRACT
INTRODUCTION: The COVID-19 pandemic highlighted advanced age and diabetes as major risk factors, with diabetic individuals particularly vulnerable to complications such as acute respiratory distress syndrome (ARDS), excessive systemic inflammation, and increased mortality. A key mechanism involves the viral spike protein (SP) binding to angiotensin-converting enzyme 2 (ACE2) receptors on endothelial cells, triggering angiotensin II (Ang II) activation and subsequent vascular dysfunction. In diabetes, pre-existing endothelial damage may further exacerbate vascular permeability, inflammation, and tissue injury.
OBJECTIVE(S): Blood samples were obtained from healthy adults (18–40 years) and diabetic patients (≥60 years) at Hospital Sultan Abdul Aziz Shah. Nitric oxide (NO) levels were quantified using the Griess assay. Human aortic endothelial cells (HAoECs) were co-treated with serum and SP and analyzed for reactive oxygen species (ROS) production, permeability, and the expression of ACE2, Ang II, ICAM-1, and VCAM-1. ACE2-transfected human bronchial epithelial cells (BEAS2b-ACE2) were co-cultured with Human Aortic Endothelial Cells (HAoECs) to assess cell death and secretion of proinflammatory cytokines and chemokines.
MATERIALS & METHODS: Diabetic plasma showed significantly lower NO levels. HAoECs exposed to both diabetic serum and SP exhibited elevated ROS, increased trans-endothelial permeability, and upregulation of ICAM-1 and VCAM-1. SP exposure reduced ACE2 expression but increased Ang II activity in BEAS2b-ACE2 cells, an effect amplified by diabetic serum, suggesting that SP-ACE2 binding promotes Ang II-mediated inflammatory signaling. SP and diabetic serum also synergistically increased chemokine release, particularly CXCL8, and epithelial cell death.
RESULTS: Diabetic plasma showed significantly lower NO levels. HAoECs exposed to both diabetic serum and SP exhibited elevated ROS, increased trans-endothelial permeability, and upregulation of ICAM-1 and VCAM-1. SP exposure reduced ACE2 expression but increased Ang II activity in BEAS2b-ACE2 cells, an effect amplified by diabetic serum, suggesting that SP-ACE2 binding promotes Ang II-mediated inflammatory signaling. SP and diabetic serum also synergistically increased chemokine release, particularly CXCL8, and epithelial cell death.
CONCLUSION: These findings suggest that diabetes-related endothelial dysfunction synergizes with SARS-CoV-2 SP activity to intensify vascular inflammation and tissue injury. The observed molecular changes may serve as biomarkers and therapeutic targets for early intervention in diabetic COVID-19 patients.
KEYWORDS: COVID-19, SARS-CoV-2, Cytokine, Coagulopathy, Endothelial Dysfunction


